Global Acne Treatment Market is anticipated to show an impressive CAGR and an exclusive growth in the forecast period of 2023-2027. The market has shown a steady growth in the historical years, 2017-2021. Owing to the major growth factors like rising teenage population, increasing issues of acne problems, and availability of the treatment the market may grow many folds in the future.
Acne treatments are conducted for the skin complications where, dead cells, dirt, and pollutants accumulate in the hair follicles present on the skin thereby clogging them in the presence of oil. These skin conditions often are found on the skin surfaces that contains large number of oil glands, like face, upper-chest and upper back.
The global acne treatment market is tending toward growth owing to the increasing pollution levels. With increasing industrialization and growing number of vehicles, the factors are directly affecting the dirt, dust and pollution levels. With everyday exposure to these pollutants, and lifestyle choices, unhealthy eating habits, preference to pain less aesthetic combination therapy procedure, among others are supporting the growth of the market for the next five years.
Global acne treatment market is segmented by therapeutic class, formulation, type, acne type, distribution channel, regional distribution and competitive landscape. Based on therapeutic class, the market is further fragmented into retinoids, antibiotics, hormonal drugs, anti-inflammatory drugs, chemical peels and others.
Antibiotics are expected to grow to the largest share while dominating the market on account of increased approval for the treatment and its property of managing the acne exudate efficiently. Retinoids are also accepted for the treatment of acne and its shares are expected to grow fastest in the next five years, following its increased manufacture and distribution in the market.
Based on acne type the market if further categorized into cystic acne, postsurgical/wound acne, comedonal acne, and inflammatory acne. Inflammatory acne is anticipated to dominate the market in next five years. Cases on inflammatory acne is increasing and it holds the largest market share.
Inflammatory acne is the skin condition when clogging in deep into the skin and the conditions worsen if the bacterial infection fosters in these lesions making the affected skin region red and swelled up. Cystic acne is the worse type of acne owing to the method of treatment required. This type of acne can only be removed surgically which is often found to be heavily affected by bacterial infection.
Some of the major competitors in the market are Novan Inc., Vyome Biosciences Pvt. Ltd., Foamix Pharmaceuticals Ltd., BioPharmX Corporation, Paratek Pharmaceuticals, Inc., Sun Pharmaceuticals Ltd., Hegde & Hegde Pharmaceutica LLP, Mankind Pharmaceuticals Ltd., Cipla Ltd., Glenmark Pharmaceuticals Limited, Stiefel Laboratories Inc., Galderma S.A., Lumenis Ltd., Cutera, Inc., Alma Lasers Ltd, among others.
Objective of the Study
- To analyze the historical growth of the market size of global acne treatment market from 2017 to 2020.
- To estimate and forecast the market size of global acne treatment market from 2021 to 2027 and growth rate until 2027.
- To classify and forecast global acne treatment market based on therapeutic class, formulation, type, acne type, distribution channel, regional distribution and competitive landscape.
- To identify dominant region or segment in the global acne treatment market.
- To identify drivers and challenges for global acne treatment market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global acne treatment market.
- To identify and analyze the profile of leading players operating in global acne treatment market.
- To identify key sustainable strategies adopted by market players in global acne treatment market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers, suppliers, and distribution channels across the country. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufactures who could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufactures, distribution channels and presence of all major players across the country.
TechSci Research calculated the market size of global acne treatment market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.
Key Target Audience
- Anti-acne drug manufacturers, end users, service providers and other stakeholders
- Distributers and suppliers of acne treatment products and other stakeholders
- Organizations, forums, and alliances related to acne treatment market
- Market research and consulting firms
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as vendors, suppliers, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
| Attribute | Details |
| Base Year | 2021 |
| Historical Years | 2017 – 2020 |
| Estimated Year | 2022 |
| Forecast Period | 2023 – 2027 |
| Quantitative Units | Revenue in USD Million and CAGR for 2017-2021 and 2022-2027 |
| Report Coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments Covered | - Therapeutic Class
- Formulation
- Type
- Acne Type
- Distribution Channel
|
| Regional Scope | North America; Asia Pacific; Europe & CIS; South America; Middle East & Africa |
| Country Scope | United States; Canada; Mexico; China; India; Japan; Australia; South Korea; Germany; France; United Kingdom; Spain; Italy; Brazil; Argentina; Colombia; Saudi Arabia; UAE; South Africa |
| Key Companies Profiled | Novan Inc., Vyome Biosciences Pvt. Ltd., Foamix Pharmaceuticals Ltd., BioPharmX Corporation, Paratek Pharmaceuticals, Inc., Sun Pharmaceuticals Ltd., Hegde & Hegde Pharmaceutica LLP, Mankind Pharmaceuticals Ltd., Cipla Ltd., Glenmark Pharmaceuticals Limited, Stiefel Laboratories Inc., Galderma S.A., Lumenis Ltd., Cutera, Inc., Alma Lasers Ltd. |
| Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
